Abstract
In 2017, inspired by the US Cancer Moonshot initiative, The Lancet Oncology published a Commission on cancer research priorities in the USA. Writing in a Comment reflecting on this Commission from a European perspective, Fortunato Ciardiello and Josep Tabernero remarked, “as scientists and doctors working in Europe, we…believe that The Lancet Oncology Commission presents research priorities that must also be discussed within the European Union (EU)...[because]…large disparities in national cancer research programmes and actions in cancer care still exist between EU countries.” This astute observation has become even more complicated in the intervening years because of the UK's exit from the EU (Brexit), the COVID-19 pandemic, the Russian invasion of Ukraine, the cost-of-living crisis, and the impending risk of a global recession.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
